Author

Caitlyn J. Durgin

Observed names: Caitlyn Durgin, Caitlyn J. Grubb

Institution: Pinney Associates (United States)

Observed institutions: Johns Hopkins University, Johns Hopkins Medicine, Pinney Associates (United States), Drexel University

ORCID: 0000-0002-8518-3410

Observed ORCID: 0000-0002-8518-3410

OpenAlex ID: A5005171309

Within subject, double blind, examination of opioid sensitivity in participant-reported, observed, physiologic, and analgesic outcomes

2023 · Caitlyn J. Durgin, Andrew S. Huhn, et al. · Drug and Alcohol Dependence Reports · 7

Abuse potential assessment of novel central nervous system active and psychedelic substances for controlled substances act scheduling recommendations

2025 · Jack E. Henningfield, Sandra D. Comer, et al. · Journal of Psychopharmacology · 5

2023 · Kelly E. Dunn, H. Elizabeth Bird, et al. · Oxford University Press eBooks · 3

Attitudes Toward Organ Donation for Persons Who Have a Substance Use Disorder Relative to Other Health Conditions

2021 · Caitlyn J. Grubb, Cecilia L. Bergeria, et al. · Frontiers in Psychiatry · 3

Inter-individual divergence in thresholds for detecting opioid effects: Within-subject human laboratory evidence of a testable behavioral phenotype

2025 · Greer McKendrick, Caitlyn J. Durgin, et al. · Drug and Alcohol Dependence · 2

Feasibility data from a novel laboratory model of spontaneous opioid withdrawal.

2026 · Dhathri Srungaram, Natalia Rincon, et al. · Experimental and Clinical Psychopharmacology

The Development of Effective and Safe Analgesics and Potential Combination Therapy Approaches: Guidances, Gaps, and Going Forward

2025 · Caitlyn Durgin, Ryan Lanier, et al. · Drug and Alcohol Dependence

Collecting Abuse-related Adverse Event Information in Clinical Trials of Psychedelics and Novel Psychoactive Drugs to Inform Scheduling and Labeling: Issues, Methods, and Recommendations

2025 · Ryan Lanier, Caitlyn Durgin, et al. · Drug and Alcohol Dependence

Real-World Abuse-Related Data for a Schedule Ii Serdexmethylphenidate and Dexmethylphenidate (SDX/d-MPH) Drug Product Suggests Low Rates of Abuse

2025 · Jack Henningfield, Charles Oh, et al. · Drug and Alcohol Dependence

Differing Approaches to Investigating the Therapeutic Efficacy of Psilocybin Across Diverse Indications

2024 · Ryan Lanier, Michael Bogenschutz, et al. · Drug and Alcohol Dependence

Abuse Potential Similarities Between Hypnotic Classes: Real-World Data

2024 · Margaret Moline, Jocelyn Cheng, et al. · Drug and Alcohol Dependence

Psychedelic Drug Abuse Potential Assessment Challenges to Scientific Validity and Real World Predictiveness: Current Approaches and Research Gaps

2024 · Jack Henningfield, August Buchhalter, et al. · Drug and Alcohol Dependence

Within-Subject Variations in Opioid Sensitivity Across Patient-Reported Outcomes, Observer-Ratings, Physiological Endpoints, and Analgesic Responses

2024 · Caitlyn Durgin, Andrew Huhn, et al. · Drug and Alcohol Dependence

Within-subject comparison of inter-individual variations in opioid-induced effects

2023 · Caitlyn Durgin, Andrew Huhn, et al. · PsycEXTRA Dataset

Works count: 14

Citation count: 20

H-index: 3

I10-index: